Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.85 PHP
Change Today +0.05 / 2.78%
Volume 20.0K
EURO On Other Exchanges
Symbol
Exchange
Philippines
As of 1:58 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

euro-med laboratories phil (EURO) Snapshot

Open
$1.81
Previous Close
$1.80
Day High
$1.85
Day Low
$1.81
52 Week High
03/31/15 - $2.89
52 Week Low
12/16/14 - $1.06
Market Cap
7.6B
Average Volume 10 Days
194.8K
EPS TTM
$0.05
Shares Outstanding
4.1B
EX-Date
06/16/14
P/E TM
38.4x
Dividend
$0.05
Dividend Yield
2.70%
Current Stock Chart for EURO-MED LABORATORIES PHIL (EURO)

Related News

No related news articles were found.

euro-med laboratories phil (EURO) Related Businessweek News

No Related Businessweek News Found

euro-med laboratories phil (EURO) Details

Euro-Med Laboratories Phil., Inc. manufactures and sells large and small volume parenterals and other solutions in the Philippines. The company operates through Manufacturing, Service, and Food Service segments. It offers parenteral products in glass and plastic containers. The company also manufactures sterile water for injection; intravenous fluids and special fluids; tablets and syrups/suspensions; antiseptic, feminine wash, cleansing, gargle, and vaginal solutions; products for nebulization and injection; intravenous sets; and other solutions, such as ophthalmic, inhalation, irrigation, and dialysis. In addition, it is involved in the operation of a dialysis center; distribution of venipuncture sets, IV administration sets, and IV equipment, as well as Limulus Amebocyte Lysate test kits; manufacture of purified and distilled drinking water; and toll manufacturing of pharmaceuticals. Further, the company is engaged in the operation of restaurants and bakeries, as well as provides food services, catering, food production, and related services. Euro-Med Laboratories Phil., Inc. exports its pharmaceutical products internationally. The company was incorporated in 1988 and is based in Manila, the Philippines. Euro-Med Laboratories Phil., Inc. operates as a subsidiary of U.S Automotive, Inc.

1,419 Employees
Last Reported Date: 04/16/15
Founded in 1988

euro-med laboratories phil (EURO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

euro-med laboratories phil (EURO) Key Developments

Euro-Med Laboratories Philippines Inc. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Euro-Med Laboratories Philippines Inc. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenues of PHP 4,703,582,459 against PHP 4,566,888,124 a year ago. Operating income was PHP 461,772,364 against PHP 423,144,446 a year ago. Income before tax was PHP 300,013,752 against PHP 272,420,598 a year ago. Net income was PHP 207,189,826 against PHP 188,721,199 a year ago. Basic and diluted earnings per share attributable to equity holders of the parent company were PHP 0.05 against PHP 0.05 a year ago. Net cash provided by operating activities was PHP 334,292,671 against PHP 231,725,644 a year ago. Acquisitions of property, plant and equipment was PHP 268,645,433 against PHP 378,230,388 a year ago.

Euro-Med Laboratories Philippines Inc., Board Meeting, Mar 24, 2015

Euro-Med Laboratories Philippines Inc., Board Meeting, Mar 24, 2015., at 17:00 Singapore Standard Time. Agenda: To hold AGM on 17 June 2015.

Euro-Med Laboratories Philippines Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Euro-Med Laboratories Philippines Inc. announced earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported operating revenue of PHP 264,578,630 against PHP 240,681,388 a year ago. Net income before tax was PHP 49,967,836 against PHP 51,513,685 a year ago. Net income attributable to parent equity holder was PHP 34,977,485 or PHP 0.01 diluted per share against PHP 36,059,579 or PHP 0.01 diluted per share a year ago. For the nine months, the company reported operating revenue of PHP 775,378,585 against PHP 721,845,864 a year ago. Net income before tax was PHP 121,689,026 against PHP 118,849,657 a year ago. Net income attributable to parent equity holder was PHP 85,182,318 or PHP 0.02 diluted per share against PHP 83,194,760 or PHP 0.02 diluted per share a year ago. As on date, book value per share was PHP 1.17 against PHP 1.2 per share as on December 31, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EURO:PM $1.85 PHP +0.05

EURO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EURO.
View Industry Companies
 

Industry Analysis

EURO

Industry Average

Valuation EURO Industry Range
Price/Earnings 36.7x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 36.5x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EURO-MED LABORATORIES PHIL, please visit www.euromedlab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.